Cargando…
First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients
BACKGROUND: First-generation drug-eluting stents (DES) have become the most widely used devices worldwide for management of coronary artery disease. As remote follow-up data were becoming available, concerns emerged in regard to their long-term safety. Second-generation DES were designed to overcome...
Autores principales: | Navarese, Eliano Pio, Kowalewski, Mariusz, Kandzari, David, Lansky, Alexandra, Górny, Bartosz, Kołtowski, Łukasz, Waksman, Ron, Berti, Sergio, Musumeci, Giuseppe, Limbruno, Ugo, van der Schaaf, Rene J, Kelm, Malte, Kubica, Jacek, Suryapranata, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189321/ https://www.ncbi.nlm.nih.gov/pubmed/25332803 http://dx.doi.org/10.1136/openhrt-2014-000064 |
Ejemplares similares
-
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis
por: Navarese, Eliano P, et al.
Publicado: (2013) -
Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
por: Navarese, Eliano Pio, et al.
Publicado: (2013) -
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents
por: Hemetsberger, Rayyan, et al.
Publicado: (2021) -
ACS network-based implementation of therapeutic hypothermia for the treatment of comatose out-of-hospital cardiac arrest survivors improves clinical outcomes: the first European experience
por: Kozinski, Marek, et al.
Publicado: (2013) -
Genetic determinants of platelet response to clopidogrel
por: Kubica, Aldona, et al.
Publicado: (2011)